Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2026 03:00 ET | Source: RQ Bio

RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention

Financing led by Frazier Life Sciences with participation from new investors EQT Life Sciences, Forbion, Monograph, Wellington Management and founding investor LifeArc VenturesProceeds support...